Page last updated: 2024-10-25

debrisoquin and Diabetes Mellitus, Type 2

debrisoquin has been researched along with Diabetes Mellitus, Type 2 in 3 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lautenschlager, MT1
Viktor, S1
Müller, UA1
Hoffmann, A1
Gawrońska-Szklarz, B1
Górnik, W1
Pawlik, A1
Kunicki, P1
Wójcicki, J1
Sitkiewicz, D1
Sych, Z1
Kallio, J1
Huupponen, R1
Viikari, J1

Trials

1 trial available for debrisoquin and Diabetes Mellitus, Type 2

ArticleYear
[Comparison of serum concentrations of caffeine, 4-methylaminoantipyrine, sulfamethazine and debrisoquin following oral administration of these substances as a cocktail in type II diabetics before and after insulin therapy].
    Die Pharmazie, 1996, Volume: 51, Issue:10

    Topics: Adult; Aged; Anti-Infective Agents; Caffeine; Central Nervous System Stimulants; Cytochrome P-450 En

1996

Other Studies

2 other studies available for debrisoquin and Diabetes Mellitus, Type 2

ArticleYear
N-acetylation and hydroxylation polymorphisms in type II diabetics with microvascular disturbances.
    European journal of clinical pharmacology, 1997, Volume: 51, Issue:6

    Topics: Acetylation; Adult; Aged; Debrisoquin; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Gen

1997
Debrisoquine hydroxylation polymorphism in diabetic patients.
    Diabetes research (Edinburgh, Scotland), 1990, Volume: 15, Issue:3

    Topics: Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Debrisoquin; Diabetes Mellitu

1990